Non-invasive Tool to Assess Electrophysiological Mechanisms in Cardiac Arrhythmias

NCT ID: NCT05772182

Last Updated: 2023-03-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

50 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-12-01

Study Completion Date

2024-06-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Noninvasive evaluation of the electrical status of the heart is based on the standard ECG but remains suboptimal due to difficulties with arrhythmia characterization and location. Electrocardiographic Imaging (ECGI) provides maps of cardiac electrical excitation in relation to the anatomy of the heart using an extensive number of electrodes from the body surface. The applicant will develop a systematic evaluation of the ECGI as a tool to detect cardiac regions of interest in cardiac arrhythmias.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The specific aim of this multicenter observational study is to evaluate the precision of non-invasive cardiac mapping system ECGI using multipolar intracardiac recordings as the gold standard. We will develop a non-invasive ECGi and intracardiac recordings in patients undergoing electrophysiology studies and/or intracardiac devices implantation to correlate the position of the regions of interest at predefined anatomy sites in patients with different organized arrhythmias. The long-term outcome of the electrophysiological characterization using ECGI will be also evaluated. Finally, the cost-efficiency of ECGI system as a support tool in cardiac arrhythmias diagnosis will be assessed.

Objectives: to perform a systematic evaluation of the ECGI with recordings using multipolar intracardiac recordings as the gold standard. Secondly, the study will also validate the ability of the ECGI recordings to increase the precision of the standard ECG interpretation by an expert.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cardiac Arrhythmia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Groups/Cohorts

Patients undergoing intervention for arrhythmia (electrophysiologic study and/or intracardiac device implantation) with clinical indication

ACORYS MAPPING SYSTEM

Intervention Type DEVICE

Diagnostic Test: ECG-Imaging

Diagnostic Test: Standard 12-lead ECG

Diagnostic Test: Endocardial mapping and/or pacing

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ACORYS MAPPING SYSTEM

Diagnostic Test: ECG-Imaging

Diagnostic Test: Standard 12-lead ECG

Diagnostic Test: Endocardial mapping and/or pacing

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Indication for an invasive electroanatomic study and/or intracardiac device implantation.
* Having obtained and signed the informed consent for study participation.
* Ability to stand, to be able to obtain the 3D torso reconstruction necessary for the ECGI system.

Exclusion Criteria

* \<18 years old
* Inability to perform an endocardial catheterization and/or device implantation.
* Physical or mental disability to understand and accept the informed consent.
* Inability to stand to obtain the 3D torso reconstruction.
* active coronary ischemia or decompensated heart failure
* Intracardiac clot on trans-esophageal echocardiography
* Pregnancy.
* Disorganized arrhythmias (i.e. atrial fibrillation, polymorphic ventricular tachycardia).
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hospital General Universitario Gregorio Marañon

OTHER

Sponsor Role collaborator

Hospital Clinic of Barcelona

OTHER

Sponsor Role collaborator

Hospital Universitario La Fe

OTHER

Sponsor Role collaborator

Corify Care S.L.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hospital Clínic de Barcelona

Barcelona, , Spain

Site Status RECRUITING

Hospital General Universitario Gregorio Marañón

Madrid, , Spain

Site Status RECRUITING

Hospital Universitari i Politècnic La Fe

Valencia, , Spain

Site Status NOT_YET_RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Spain

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Felipe Atienza, MD, PhD

Role: CONTACT

915868000 ext. 0034

Andreu Climent, PhD

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Lluís Mont, MD, PhD

Role: primary

932275400 ext. 0034

Felipe Atienza, MD, PhD

Role: primary

915868000 ext. 0034

Joaquín Osca, MD, PhD

Role: primary

961244000 ext. 0034

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SAVE-COR

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.